This article is excerpted from a letter by Mordechai Yavneh, managing member at Focus Capital Management, based in New York.
Description
Viemed is a healthcare company operating in the US market. Viemed’s main focus is ventilators, particularly non-invasive ventilators that are provided in the home for late-stage COPD patients. Viemed trades both on the Toronto Stock Exchange in Canadian Dollars (CAD) and on the NASDAQ in US Dollars (USD).
Members, log in below to access the restricted content.
Not a member?
Thank you for your interest. Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:
About The Author: Mordechai Yavneh
Mordechai Yavneh is the founder and manager of New York-based Focus Capital Management, LLC, a boutique long-only hedge fund launched in 2013. Focus Capital Management is a fund with a fairly unique approach to investing. Our unique advantage comes from implementing and capitalizing on the value that concentration brings to an investor’s portfolio. We believe that focusing our time, energy, research, analysis, and resources on our best ideas generates superior long-term returns with a reduced level of risk built into each investment. We aim to invest in 4-5 positions at a time, and we believe this concentration and the deep research we invest in each of our positions is the catalyst behind our long-term success.
More posts by Mordechai Yavneh